The gamma-glutamyltransferase (GGT) is recognized in medical practice as a useful indicator for the detection of liver lesions, especially those induced by the excessive consumption of alcoholic or cholesterol-associated drinks. The present study, although it includes a very small number of cases diagnosed with colon diverticulosis-diverticulitis associated with polyposis at the same intestinal level, identifies the presence of increased circulating concentrations of this enzyme in the serum. Its serum levels are tracked "dynamically" throughout a year after the diagnosis and start of the therapy. The study calls into question the release of the enzyme from the edge of the enterocytes' brush-like edge, leading to the pathogenic disturbance of regional redox homeostasis. The hypothesis gives the circulating values of GGT predictive value for cellular oxidative stress, as well as for indirectly expressing the glutathione level in cytosol.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009901PMC
http://dx.doi.org/10.1080/14756366.2018.1428802DOI Listing

Publication Analysis

Top Keywords

gamma-glutamyltransferase novel
4
novel biomarker
4
biomarker colon
4
colon diverticulosis
4
diverticulosis case-control
4
case-control study
4
study gamma-glutamyltransferase
4
gamma-glutamyltransferase ggt
4
ggt recognized
4
recognized medical
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!